Literature DB >> 20512930

Characterization of an Importin alpha/beta-recognized nuclear localization signal in beta-dystroglycan.

Bárbara Lara-Chacón1, Mario Bermúdez de León, Daniel Leocadio, Pablo Gómez, Lizeth Fuentes-Mera, Ivette Martínez-Vieyra, Arturo Ortega, David A Jans, Bulmaro Cisneros.   

Abstract

Beta-dystroglycan (beta-DG) is a widely expressed transmembrane protein that plays important roles in connecting the extracellular matrix to the cytoskeleton, and thereby contributing to plasma membrane integrity and signal transduction. We previously observed nuclear localization of beta-DG in cultured cell lines, implying the existence of a nuclear targeting mechanism that directs it to the nucleus instead of the plasma membrane. In this study, we delineate the nuclear import pathway of beta-DG, characterizing a functional nuclear localization signal (NLS) in the beta-DG cytoplasmic domain, within amino acids 776-782. The NLS either alone or in the context of the whole beta-DG protein was able to target the heterologous GFP protein to the nucleus, with site-directed mutagenesis indicating that amino acids R(779) and K(780) are critical for NLS functionality. The nuclear transport molecules Importin (Imp)alpha and Impbeta bound with high affinity to the NLS of beta-DG and were found to be essential for NLS-dependent nuclear import in an in vitro reconstituted nuclear transport assay; cotransfection experiments confirmed the dependence on Ran for nuclear accumulation. Intriguingly, experiments suggested that tyrosine phosphorylation of beta-DG may result in cytoplasmic retention, with Y(892) playing a key role. beta-DG thus follows a conventional Impalpha/beta-dependent nuclear import pathway, with important implications for its potential function in the nucleus. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512930     DOI: 10.1002/jcb.22581

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

Review 1.  Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene.

Authors:  Ramin Tadayoni; Alvaro Rendon; L E Soria-Jasso; Bulmaro Cisneros
Journal:  Mol Neurobiol       Date:  2011-11-22       Impact factor: 5.590

2.  The extracellular matrix protein agrin is essential for epicardial epithelial-to-mesenchymal transition during heart development.

Authors:  Xin Sun; Sophia Malandraki-Miller; Tahnee Kennedy; Elad Bassat; Konstantinos Klaourakis; Jia Zhao; Elisabetta Gamen; Joaquim Miguel Vieira; Eldad Tzahor; Paul R Riley
Journal:  Development       Date:  2021-05-10       Impact factor: 6.868

3.  Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.

Authors:  G Mathew; A Mitchell; J M Down; L A Jacobs; F C Hamdy; C Eaton; D J Rosario; S S Cross; S J Winder
Journal:  Sci Rep       Date:  2013-09-30       Impact factor: 4.379

4.  Whole exome sequencing identified a novel DAG1 mutation in a patient with rare, mild and late age of onset muscular dystrophy-dystroglycanopathy.

Authors:  Yi Dai; Shengran Liang; Xue Dong; Yanhuan Zhao; Haitao Ren; Yuzhou Guan; Haifang Yin; Chen Li; Lin Chen; Liying Cui; Santasree Banerjee
Journal:  J Cell Mol Med       Date:  2018-11-18       Impact factor: 5.310

5.  Nuclear import of β-dystroglycan is facilitated by ezrin-mediated cytoskeleton reorganization.

Authors:  Alejandra Vásquez-Limeta; Kylie M Wagstaff; Arturo Ortega; Dorothy H Crouch; David A Jans; Bulmaro Cisneros
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

6.  Expression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease.

Authors:  Mary Luz Uribe; Carmen Haro; María Paz Ventero; Laura Campello; Jesús Cruces; José Martín-Nieto
Journal:  Mol Vis       Date:  2016-06-16       Impact factor: 2.367

7.  Dystroglycan Depletion Impairs Actin-Dependent Functions of Differentiated Kasumi-1 Cells.

Authors:  Marco Antonio Escárcega-Tame; Ivette Martínez-Vieyra; Lea Alonso-Rangel; Bulmaro Cisneros; Steve J Winder; Doris Cerecedo
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

8.  γ-Secretase Dependent Nuclear Targeting of Dystroglycan.

Authors:  Daniel Leocadio; Andrew Mitchell; Steve J Winder
Journal:  J Cell Biochem       Date:  2016-03-31       Impact factor: 4.429

9.  Retrograde trafficking of β-dystroglycan from the plasma membrane to the nucleus.

Authors:  Viridiana Gracida-Jiménez; Ricardo Mondragón-González; Griselda Vélez-Aguilera; Alejandra Vásquez-Limeta; Marco S Laredo-Cisneros; Juan de Dios Gómez-López; Luis Vaca; Sarah C Gourlay; Laura A Jacobs; Steve J Winder; Bulmaro Cisneros
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

10.  Dasatinib as a treatment for Duchenne muscular dystrophy.

Authors:  Leanne Lipscomb; Robert W Piggott; Tracy Emmerson; Steve J Winder
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.